Welcome to our dedicated page for Ryan Specialty Holdings news (Ticker: $RYAN), a resource for investors and traders seeking the latest updates and insights on Ryan Specialty Holdings stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Ryan Specialty Holdings's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Ryan Specialty Holdings's position in the market.
Ryan Specialty Holdings, Inc. reported a strong first quarter in 2024 with total revenue growing 20.6% year-over-year to $552.0 million, net income of $40.7 million, and adjusted EBITDAC increasing 25.8% to $157.2 million. The company had exceptional performance with double-digit organic growth and improvements in margin profile. With a positive outlook for 2024, Ryan Specialty is focused on sustainable and profitable growth.
Ryan Specialty, a leading international specialty insurance firm, has completed the acquisition of Castel Underwriting Agencies , a Managing General Underwriting platform. Castel brings new products and facilities, expanding offerings to clients and trading partners. The enhanced leadership team will accelerate de novo formations in the region.